The Good, the Bad, and the Ugly: Hyperprogression in Cancer Patients Following Immune Checkpoint Therapy
Genome Medicine - United Kingdom
doi 10.1186/s13073-019-0661-7
Full Text
Open PDFAbstract
Available in full text
Date
July 24, 2019
Authors
Publisher
Springer Science and Business Media LLC